Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Nitrate in PH-HFpEF and Healthy Adults
NCT02980068Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dietary nitrate in pulmonary hypertension (PH) and heart failure with preserved ejection fraction (HFpEF) (2 arms). Primary endpoints: Change in nitrate level in urine at 6 hours, Change in nitrate level in plasma at 6 hours and 4 more. Started Aug 2017; status: completed.
02
Drugs
dietary nitrate
03
Conditions
pulmonary hypertension (PH)heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02980068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980068.